A vaccine for the most commonly reported sexually transmitted infection in the U.S.—the bacterial disease chlamydia—is now a substantial step closer to reality. On Monday, researchers reported that two of their vaccine candidates were found to be safe in a phase 1 clinical trial of 35 women. Though the trial wasn’t…
Read more…
Source : A Chlamydia Vaccine Shows Promise in Early Human Trial
